The toxicity of<unk>  and dieldrin is determined by the results of several animal studies. Reports of a significant increase in workers death in relation to<unk>  has not been found, although death by anemia is reported in some cases after multiple exposure to<unk> . Immunological tests linked an antigenic response to erythrocytes coated with dieldrin in those cases. Direct dose-response relations being a cause for death are yet to be examined. The NOAEL that was derived from rat studies: * The minimal risk level at acute oral exposure to<unk>  is 0.002 mg/kg/day. * The minimal risk level at intermediate exposure to Dieldrin is 0.0001 mg/kg/day. * The minimal risk level at chronic exposure to<unk>  is 0.00003 mg/kg/day. * The minimal risk level at chronic exposure to Dieldrin is 0.00005 mg/kg/day. In addition to these studies, breast cancer risk studies were performed demonstrating a significant increased breast cancer risk. After comparing blood concentrations to number of lymph nodes and tumor size a 5-fold higher risk of death was determined, comparing the highest quartile range in the research to the lower quartile range. Young children are also more susceptible to the drug, causing severe generalized convulsions.
Aldrin
Haptocorrin
Anordrin
Equilin
Pentostatin
Endrin
Tetanospasmin
Modulin